CR8492A - B-hidroxi esteres heteroaromaticos opticamente activos, procesos para su preparacion a partir de b-ceto esteres y procesos para la preparacion de dichos b-ceto esteres - Google Patents

B-hidroxi esteres heteroaromaticos opticamente activos, procesos para su preparacion a partir de b-ceto esteres y procesos para la preparacion de dichos b-ceto esteres

Info

Publication number
CR8492A
CR8492A CR8492A CR8492A CR8492A CR 8492 A CR8492 A CR 8492A CR 8492 A CR8492 A CR 8492A CR 8492 A CR8492 A CR 8492A CR 8492 A CR8492 A CR 8492A
Authority
CR
Costa Rica
Prior art keywords
esteres
ceto
processes
preparation
optically active
Prior art date
Application number
CR8492A
Other languages
English (en)
Inventor
Platzek Johannes
Zorn Ludwig
Buchmann Bern
Skuballa Werner
Petrov Orlin
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CR8492A publication Critical patent/CR8492A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14—Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

La presente invencion se refiere a B-hidroxiesteres heteroatomicos opticamente activos utiles en la sintesis de derivados de epotilona, a ciertos compuestos utilizados para producir tales intermediarios, asi como a procedimientos para su produccion.
CR8492A 2003-12-31 2006-06-28 B-hidroxi esteres heteroaromaticos opticamente activos, procesos para su preparacion a partir de b-ceto esteres y procesos para la preparacion de dichos b-ceto esteres CR8492A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10361794A DE10361794B3 (de) 2003-12-31 2003-12-31 Optisch aktive heteroaromatische ß-Hydroxy-Ester und Verfahren zu deren Herstellung sowie deren Verwendung als Zwischenprodukte bei der Epothilon-Totalsynthese

Publications (1)

Publication Number Publication Date
CR8492A true CR8492A (es) 2007-03-08

Family

ID=34716267

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8492A CR8492A (es) 2003-12-31 2006-06-28 B-hidroxi esteres heteroaromaticos opticamente activos, procesos para su preparacion a partir de b-ceto esteres y procesos para la preparacion de dichos b-ceto esteres

Country Status (17)

Country Link
EP (1) EP2113031A1 (es)
JP (1) JP2007516999A (es)
KR (1) KR20070029641A (es)
CN (1) CN100510098C (es)
AU (1) AU2004309076A1 (es)
BR (1) BRPI0418254A (es)
CA (1) CA2546981A1 (es)
CR (1) CR8492A (es)
DE (1) DE10361794B3 (es)
EC (1) ECSP066740A (es)
HK (1) HK1097000A1 (es)
IL (1) IL175908A0 (es)
MX (1) MXPA06007564A (es)
NO (1) NO20063477L (es)
RU (1) RU2006127553A (es)
WO (1) WO2005064006A1 (es)
ZA (1) ZA200606293B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104328152A (zh) * 2014-10-13 2015-02-04 青岛科技大学 一种产朊酵母催化生产亚环己基烯醇的方法
CN108118004B (zh) * 2017-12-15 2021-06-25 北京工商大学 一株喜仙人掌毕赤酵母在水果采后病害防治中的应用
CN111689982B (zh) * 2019-03-15 2023-04-07 博瑞生物医药（苏州）股份有限公司 艾日布林中间体及其制备方法
CN110283733B (zh) * 2019-06-20 2020-10-27 浙江工业大学 土星轮头酵母zjph1807及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7257096A (en) * 1995-10-04 1997-04-28 Fmc Corporation Herbicidal 6-heterocyclic indazole derivatives
US5942644A (en) * 1997-05-27 1999-08-24 Biocatalytics, Inc. Precursors for the production of chiral vicinal aminoalcohols
US6211412B1 (en) * 1999-03-29 2001-04-03 The University Of Kansas Synthesis of epothilones
AR023792A1 (es) * 1999-04-30 2002-09-04 Bayer Schering Pharma Ag Derivados 6-alquenilo- y 6-alquinilo-epotilona, los procedimientos para prepararlos y su empleo en productos farmaceuticos
JP2001213874A (ja) * 1999-07-22 2001-08-07 Mercian Corp イソクマリン誘導体の製造およびそのための中間体
DE10041470A1 (de) * 2000-08-18 2002-02-28 Schering Ag 12,13-Cyclopropyl-Epothilon-Derivate, Verfahren zu deren Herstellung sowie ihre Verwendung in pharmazeutischen Präparaten
WO2003029195A1 (fr) * 2001-09-28 2003-04-10 Sumika Fine Chemicals Co., Ltd. Intermediaires pour l'elaboration d'un derive de l'epothilone, et leur procede de production
JP4432315B2 (ja) * 2002-03-19 2010-03-17 三菱化学株式会社 光学活性３−ヒドロキシ−３−（２’−チエニル）プロピオン酸エステル誘導体の製造方法

Also Published As

Publication number Publication date
HK1097000A1 (en) 2007-06-15
DE10361794B3 (de) 2005-10-06
NO20063477L (no) 2006-08-23
KR20070029641A (ko) 2007-03-14
ECSP066740A (es) 2006-10-31
CN100510098C (zh) 2009-07-08
MXPA06007564A (es) 2006-12-14
CN1902322A (zh) 2007-01-24
AU2004309076A1 (en) 2005-07-14
EP2113031A1 (en) 2009-11-04
JP2007516999A (ja) 2007-06-28
CA2546981A1 (en) 2005-07-14
ZA200606293B (en) 2009-08-26
WO2005064006A1 (en) 2005-07-14
RU2006127553A (ru) 2008-02-10
BRPI0418254A (pt) 2007-04-17
IL175908A0 (en) 2006-10-05

Similar Documents

Publication Publication Date Title
UY30578A1 (es) Nuevos derivados de 2,4??- y 3, 4??-bipiridina sustituidos, procedimientos para su preparacion, medicamentos conteniéndolos y aplicaciones
WO2011054818A3 (de) Neue, nicht kristallisierende methacrylate, deren herstellung und verwendung
EA200702329A1 (ru) Замещенные пирролпиридины, содержащие их композиции, способ получения и применение
WO2008083950A8 (de) Spirocyclische tetronsäure-derivative
CY1110209T1 (el) Υποκατεστημενες ενωσεις βενζο(d)ισοξαζολ-3-υλ-αμινης σαν αναλγητικα
ECSP10010582A (es) Derivados de aminodihidrotiazina como inhibidores de bace para el tratamiento de la enfermedad de alzheimer
IL219163A0 (en) A process for the preparation of optically active chiral amines
ATE527266T1 (de) Herstellungsverfahren für asenapin und in diesem verfahren verwendete zwischenprodukte
MX2011009369A (es) 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
MX2009003382A (es) Derivados de sulfonamidas sustituidos.
CY1111407T1 (el) ΜΕΘΟΔΟΙ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ ΕΞΑΫΔΡΟΦΟΥΡΟ[2,3-b)]ΦΟΥΡΑΝ-3-ΟΛΗΣ
WO2010102778A3 (de) Substituierte 3-aminoisoxazolopyridine als kcnq2/3 modulatoren
AR048938A1 (es) Cepas de levadura que producen colesterol y sus aplicaciones
WO2006024387A3 (de) Biphenylthiazolcarboxamide
WO2007126893A3 (en) A convergent process for the synthesis of taxane derivatives
CR10557A (es) Bencilaminas, un proceso para la produccion y su uso como agentes antiinflamatorios
ATE519373T1 (de) Teezusammensetzung und herstellungsverfahren dafür
ATE425961T1 (de) Salze substituierter allophansaureester und deren verwendung in arzneimitteln
CR11452A (es) 5-((3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino)-1h-quinolin-2-onas, un proceso para su produccion y su uso como agentes antiflamatorios
ECSP088569A (es) Nuevos derivados de furopirimidina acíclicos sustituidos y uso de los mismos para el tratamiento de enfermedades cardiovasculares
CY1109569T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
MX2011009338A (es) 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3.
CR8492A (es) B-hidroxi esteres heteroaromaticos opticamente activos, procesos para su preparacion a partir de b-ceto esteres y procesos para la preparacion de dichos b-ceto esteres
DK2314560T3 (da) Fremgangsmåder til produktionen af xylitol
WO2007115929A8 (de) Thiazolyl-dihydro-quinazoline

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)